Level Biotechnology (3118) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 進階

Level Biotechnology (3118) reported revenue of NT$46.3 million for Oct 2026, -8.2% year on year and -27.4% from the previous month. Revenue for Jan–Oct 2026 was NT$553.6 million (-7.6% year on year).

In Oct 2026, it ranked No. 102 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$65.4 million24/10Nov 2024 NT$66.9 millionDec 2024 NT$72.4 millionJan 2025 NT$46.1 millionFeb 2025 NT$61 million25/02Mar 2025 NT$69.8 millionApr 2025 NT$60.4 millionMay 2025 NT$54.4 millionJun 2025 NT$56.8 million25/06Jul 2025 NT$62.1 millionAug 2025 NT$67.8 millionSep 2025 NT$70.2 millionOct 2025 NT$50.4 million25/10Nov 2025 NT$58.9 millionDec 2025 NT$78.7 millionJan 2026 NT$57.2 millionFeb 2026 NT$31.3 million26/02Mar 2026 NT$70.3 millionApr 2026 NT$58.2 millionMay 2026 NT$49.4 millionJun 2026 NT$54.7 million26/06Jul 2026 NT$65.5 millionAug 2026 NT$56.8 millionSep 2026 NT$63.7 millionOct 2026 NT$46.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$46.3 million-8.2%-27.4%
Sep 2026NT$63.7 million-9.2%+12.2%
Aug 2026NT$56.8 million-16.2%-13.3%
Jul 2026NT$65.5 million+5.5%+19.7%
Jun 2026NT$54.7 million-3.6%+10.8%
May 2026NT$49.4 million-9.1%-15.2%
Apr 2026NT$58.2 million-3.6%-17.2%
Mar 2026NT$70.3 million+0.7%+124.3%
Feb 2026NT$31.3 million-48.6%-45.2%
Jan 2026NT$57.2 million+24.2%-27.3%
Dec 2025NT$78.7 million+8.7%+33.5%
Nov 2025NT$58.9 million-12.0%+16.8%
Oct 2025NT$50.4 million-22.9%-28.1%
Sep 2025NT$70.2 million+24.0%+3.5%
Aug 2025NT$67.8 million+3.8%+9.2%
Jul 2025NT$62.1 million+3.0%+9.4%
Jun 2025NT$56.8 million-6.4%+4.4%
May 2025NT$54.4 million-3.5%-10.0%
Apr 2025NT$60.4 million+23.0%-13.5%
Mar 2025NT$69.8 million-9.5%+14.5%
Feb 2025NT$61 million+46.5%+32.4%
Jan 2025NT$46.1 million-22.6%-36.4%
Dec 2024NT$72.4 million+6.5%+8.2%
Nov 2024NT$66.9 million+9.1%+2.3%
Oct 2024NT$65.4 million+8.7%+15.6%

Jan–Oct 2026 cumulative: NT$553.6 million (-7.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Level Biotechnology vs PEC / Level Biotechnology vs Lotus Pharm / Level Biotechnology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16